Innovation
“Innovation is the key to sustainability, and also a promise to improve human lives.
Innovation
“Innovation is the key to sustainability, and also a promise to improve human lives.
In the pharmaceutical industry, Research and Development is not just about identification of newer and novel compounds, it is also about its suitability, sustainability, social ramifications and finally whether the prospective drug will reward the concerned maker with financial growth. Nonetheless, the aim of every new research ( candidate drug ) is to identify its therapeutic benefits and its pain relieving parameter.
At Archerchem, innovation has a different meaning altogether. We tread a signature research path, unique only to us. Our therapeutic products are built around strict principles of strategic orientation and operations, and these fundamentals help us build a portfolio of high quality branded and generic medicines for global markets.
We don’t just focus on the discovery of radical drugs. We aim at providing these are a ‘humane’ price. It calls for a dynamic shift from traditional manufacturing practices while all our proprietary drugs carry quality technical documents ( Leaflets ) which are compliant with ICH guidelines.
As mentioned above, our focus has always been on developing novel drugs based around the following consumption mechanisms -
Our growth and patient-focused Research and Development model is extremely well-balanced, allowing us to innovate, improve and sustain at the same time, especially in the emerging markets, although most of our efforts are targeted towards regulated markets of USA and Europe.
Archerchem’s new generation, innovative branded products improve the quality of human lives without potential side-effects and therefore its impact / disruption on daily routines are minimal.
Our team of highly experienced scientists works round the clock on the essential areas of Research and Development which includes - new formulations, stability and degradation studies, quality assurance, documentation and filing of technical data with the concerned regulatory authorities.
